Drug Type Biological products |
Synonyms- |
Mechanism MERS-CoV spike protein inhibitors(MERS-CoV spike protein inhibitors), SARS-CoV S protein inhibitors(SARS-CoV S protein inhibitors), SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Severe Acute Respiratory Syndrome | Preclinical | US | 16 Feb 2023 |